Editorial comment

Curr Opin Urol. 2017 Jan;27(1):34. doi: 10.1097/MOU.0000000000000358.
No abstract available

Publication types

  • Introductory Journal Article

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / genetics*
  • Drug Resistance, Neoplasm / genetics
  • Epigenesis, Genetic*
  • Genomics / methods
  • Humans
  • Precision Medicine / methods
  • Rare Diseases / diagnosis
  • Rare Diseases / genetics*
  • Rare Diseases / therapy
  • Urologic Neoplasms / diagnosis
  • Urologic Neoplasms / genetics*
  • Urologic Neoplasms / therapy

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor